D017473Chemicals & DrugsD12.776.543.750.695.620.400D12.776.543.750.720.600.610.400D12.776.543.750.750.555.610.400330.997823Receptors, Opioid, kappaFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPsychiatryCelesteNapierCeleste Napier41.87386750000000-87.67102690000000349114Napier, CelesteProfessorElizabethBerry-KravisElizabeth Berry-Kravis349548Berry-Kravis, ElizabethProfessorJohnZajeckaJohn Zajecka349738Zajecka, JohnProfessor4Professor33125454Fava M, Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, Macaluso M, Morrison MF, Carpenter LL, Shelton R, Zajecka J, Papakostas GIAnnals of clinical psychiatry : official journal of the American Academy of Clinical PsychiatristsDouble-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Ann Clin Psychiatry. 2020 02; 32(4):18-26.Ann Clin Psychiatry2020-02-01T00:00:002020Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.Neurological SciencesRush University, Rush Medical College0.2136280.03523213research area of0.7498470.1412363subject area fortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor11849293Mitrovic I, Napier TCThe European journal of neuroscienceMu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci. 2002 Jan; 15(2):257-68.Eur J Neurosci2002-01-01T00:00:002002Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum.8614281Banerjee P, Chromy BA, Berry-Kravis E, Hammond D, Singh JK, Dawson GLife sciencesStable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and nonneural origin. Life Sci. 1996; 58(15):1277-84.Life Sci1996-01-01T00:00:001996Stable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and nonneural origin.